Oscotec Inc.

Industry · 8 registered clinical trials — 1 currently recruiting.

Status	Trial	Phase	Started
Recruiting	Study to Assess the Effect of OCT-598 in Patients With Advanced Solid Tumors Solid Tumor, Breast Cancer, Head and Neck Cancer	Phase 1	2025-12-18
Unknown	A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SKI-G-801 in Patients With Advanced Soli Advanced Solid Tumor	Phase 1	2022-01-25
Completed	A Study of the Absorption, Metabolism, and Excretion of [14C]-SKI-O-703 Following a Single Oral Dose in Health Healthy Volunteers	EARLY_Phase 1	2021-08-10
Completed	Study of Oral SKI-O-703, SYK Inhibitor, in Patients With Persistent and Chronic Immune Thrombocytopenia (ITP) Immune Thrombocytopenia	Phase 2	2019-10-11
Completed	A Study to Evaluate the Effectiveness and Safety of SKI-O-703 in Patients Experiencing Active Rheumatoid Arthr Rheumatoid Arthritis	Phase 2	2019-03-20
Completed	Study to Find a Safe and Effective Dose of SKI-G-801 in the Treatment of Patients With Acute Myeloid Leukemia Acute Myeloid Leukemia	Phase 1	2018-02-23
Completed	Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of SKI-O-703 in Healthy Volunteers Arthritis, Rheumatoid	Phase 1	2016-09-22
Completed	Safety, Tolerability, and Pharmacokinetics of a Single Oral Dose of SKI-O-703 in Healthy Volunteers Rheumatoid Arthritis	Phase 1	2015-09-01